The news at a glance

Pfizer: A sudden change at the top; E-business: Splitsville for Diller and Malone; Aviation: Qantas sues Rolls-Royce over engines; Consumer privacy: A ‘Don’t Track’ Web option?; Takeover: Groupon spurns Google

Pfizer: A sudden change at the top

Pfizer Chairman and CEO Jeffrey Kindler resigned unexpectedly this week, citing the “extremely demanding” nature of his job, said Simon Kennedy and Sarah Turner in Marketwatch.com. Ian Read, 57, a 32-year veteran of the company who heads the drugmaker’s global biopharmaceutical operations, will succeed him. Kindler, 55, faced a daunting set of challenges when he became CEO in 2006, including “big changes to the health-care marketplace and the upcoming expiration of major patents, including blockbuster cholesterol drug Lipitor,” one of the world’s best-selling drugs. He spearheaded last year’s $68 billion acquisition of Wyeth “in part to compensate for Lipitor’s loss.”

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More